Sign in

CIK 0001833214 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

SAB Biotherapeutics, Inc.

Sign in to watch
Ticker
SABS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
853899721
Phone
305-845-2813
Business address
777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
Former names
Big Cypress Acquisition Corp.
  1. 4 Insider Changes in Ownership
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. 10-Q Report Quarterly Report
  5. 424B3 Offering Prospectus
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. SCHEDULE 13D Stake Beneficial Ownership Report
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. EFFECT Other Notice of Effectiveness
  12. 8-K Event Executive or director change
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. 8-K Event Executive or director change · Shareholder vote results
  15. S-3/A Offering Registration Statement
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. 4 Insider Changes in Ownership
  18. UPLOAD Other SEC-generated Letter
  19. S-3 Offering Registration Statement
  20. DEF 14A Proxy Proxy Statement

Page 4 of 22 · 433 filings